# Recurrent Pediatric Extrapleural Solitary Fibrous Tumor of the Jaw

**Authors:** Baishakhi Modak, Vishwapriya Mahadev Godkhindi, Narayana Venkadasalapathy, Raghu Radhakrishnan

PMC · DOI: 10.1007/s12105-025-01816-9 · Head and Neck Pathology · 2025-07-29

## TL;DR

A 13-year-old boy with a rare aggressive tumor in his jaw faced recurrence and died before a second surgery.

## Contribution

This case report highlights a rare extrapleural dedifferentiated solitary fibrous tumor in a pediatric patient.

## Key findings

- The tumor was confirmed via histopathology and immunohistochemistry as a dedifferentiated solitary fibrous tumor.
- The tumor recurred after initial surgical excision and the patient died before a second surgery.
- Immunohistochemical markers included CD34, STAT6, MyoD1, α-SMA, Bcl-2, and CD99.

## Abstract

Solitary fibrous tumors encompass a heterogeneous group of spindle cell neoplasms, ranging from biologically low-risk lesions to, in rare instances, highly aggressive tumors with malignant potential. Dedifferentiation in solitary fibrous tumors is uncommon and typically occurs in the retroperitoneum, with extrapleural involvement being among the least frequently reported.

A 13-year-old male presented with a rapidly enlarging mass in the lower jaw of 20 days duration, involving the submandibular triangle and floor of the mouth.

Histopathological examination of the excisional biopsy revealed spindle-shaped cells arranged in compact fascicles with a haphazard distribution, and areas of hyalinization. Immunohistochemical analysis demonstrated positivity for CD34, STAT6, MyoD1, α-SMA, Bcl-2, and CD99, confirming the diagnosis of extrapleural dedifferentiated solitary fibrous tumor (DSFT).

The lesion was surgically excised but recurred, likely due to disease progression. Re-excision was planned, but the child died 10 days before surgery.

## Linked entities

- **Genes:** CD34 (CD34 molecule) [NCBI Gene 947], STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 6778], MYOD1 (myogenic differentiation 1) [NCBI Gene 4654], ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], CD99 (CD99 molecule (Xg blood group)) [NCBI Gene 4267]
- **Diseases:** solitary fibrous tumor (MONDO:0016238), dedifferentiated solitary fibrous tumor (MONDO:0006178)

## Full-text entities

- **Genes:** STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 6778] {aka D12S1644, HIES6, IL-4-STAT, STAT6B, STAT6C}, MYOD1 (myogenic differentiation 1) [NCBI Gene 4654] {aka CMYO17, CMYP17, MYF3, MYOD, MYODRIF, PUM}, CD34 (CD34 molecule) [NCBI Gene 947], CD99 (CD99 molecule (Xg blood group)) [NCBI Gene 4267] {aka HBA71, MIC2, MIC2X, MIC2Y, MSK5X}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}
- **Diseases:** spindle cell neoplasms (MESH:D002277), Fibrous Tumor (MESH:D009369), DSFT (MESH:D054364)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12307823/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12307823/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12307823/full.md

---
Source: https://tomesphere.com/paper/PMC12307823